News

Vivamus vulputate bibendum diam id facilisis. Morbi id nisi non mi ullamcorper feugiat. Duis sem ante, rhoncus eu ultrices vitae, vehicula vitae mauris. Donec id aliquet est, quis gravida felis. Suspendisse semper ut dui at semper.
Press Releases
Senate Confirms Dr. Hahn to Lead the Food and…
Former Congressman Jim Greenwood, President and CEO of the Biotechnology Innovation Organization (BIO), issued the following statement after the U.S. Senate confirmed Dr. Stephen Hahn to serve as the next commissioner of the Food and Drug…
BIO’s Jim Greenwood on H.R. 3: “Let’s Move Past…
Trump Administration and Speaker Pelosi Surrender…
Exclusion of biologics provisions in revised USMCA sets dangerous precedent for future trade talks, including with China Puts American jobs, intellectual property and leadership in medical innovation at risk WASHINGTON – BIO President and CEO Jim…
Letters, Testimony, & Comments
More than 135 Emerging Biotech Leaders Urge…
In a letter addressed to House Speaker Nancy Pelosi (D-CA) and House Republican Leader Kevin McCarthy (R-CA), 138 emerging biotech leaders warn that H.R. 3, the Lower Drug Cost Now Act, will “shatter the dreams” of patients and families who stand to…
BIO Comments on RFS Standards for 2020 and…
BIO's comments on the EPA’s administration of the of the Renewable Fuel Standard (RFS)  program and how it has put the investments made by BIO Member companies at risk and threatens to prevent growth in advanced and cellulosic biofuels as the…
BIO Comments on FDA docket Standards for Future…
Biotechnology Innovation Organization (BIO) comments on the FDA docket, Standards for Future Opioid Analgesic Approvals and Incentives for New Therapeutics to Treat Pain and Addiction. BIO also believes that risks associated with opioid…
Amicus Briefs
BIO Files Amicus Brief in Support of Rehearing…
BIO files amicus brief in support of a petition for rehearing related to patent-eligibility of diagnostic technology. 
BIO Files Amicus Brief on Case Addressing the…
BIO files an Amicus Brief on rehearing by the Precedential Opinion Panel of the Patent Trial and Appeal Board.
BIO Files Amicus Brief on Case Addressing…
BIO and PhRMA have submitted a brief in the U.S Court of Appeals for the Federal Circuit on behalf of appellant in Virnetx Inc. v. The Mangrove Partners. 
Blog Posts
This Major Breakthrough Could Help Improve Global Food Supply
December 4, 2019
On December 5,  United Nations World Soil Day 2019 (#WorldSoilDay) and its campaign "Stop soil erosion, Save our future" raises awareness on the importance of sustaining healthy ecosystems …
Welcome to the new bio.org
November 26, 2019
Welcome to the all-new BIO.org! BIO.org is now your one-stop-shop for everything BIO, from information and resources on our advocacy and policy work, to everything you need to know about BIO events.  For the first…
Patient & Health Advocacy Summit
November 18, 2019
After 30-plus years working in Washington DC, it’s clear healthcare decision makers recognize that a patient’s story can add value to a discussion when data cannot. While the value of data is not disputed, the art…